Parkinson's Blog


HELP & HOPE: Montcalm Area Parkinson’s Support Group resumes monthly meetings

Now that a COVID-based hiatus is over, this winter the Montcalm Area Parkinson’s Support Group has resumed monthly meetings. With approximately 90,000 new diagnoses of Parkinson’s disease each year and more than 10 million people currently living with the disease, it was beyond time to reactivate the local support group for individuals with Parkinson’s and their caregivers in the Montcalm, Ionia and northern Kent county areas.

Amneal Announces Complete Response Resubmission for IPX203 New Drug Application

BRIDGEWATER, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”) today announced that it has provided a Complete Response resubmission to the U.S. Food and Drug Administration (FDA) for IPX203, a novel, oral formulation of carbidopa/levodopa (CD/LD) extended-release capsules for the treatment of Parkinson’s disease (PD). The original NDA for IPX203 resulted in a Complete Response Letter (CRL) from FDA. The resubmission package included